It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.Zacks Premium also includes the Zacks Style Scores. What ...

Core Viewpoint - Investors in the Medical - Dental Supplies sector should consider Align Technology (ALGN) and Straumann Holding AG (SAUHY) as potential value opportunities, with ALGN currently presenting a superior value option based on various valuation metrics [1][7]. Valuation Metrics - Both ALGN and SAUHY hold a Zacks Rank of 2 (Buy), indicating a positive earnings outlook due to favorable analyst estimate revisions [3]. - ALGN has a forward P/E ratio of 18.33, while SAUHY has a higher forward P/E of 30.67, suggesting that ALGN may be undervalued compared to SAUHY [5]. - The PEG ratio for ALGN is 1.63, indicating a more favorable valuation relative to its expected earnings growth compared to SAUHY's PEG ratio of 2.14 [5]. - ALGN's P/B ratio is 3.65, significantly lower than SAUHY's P/B ratio of 8.9, further supporting ALGN's position as a better value stock [6]. - Based on these valuation figures, ALGN earns a Value grade of B, while SAUHY receives a Value grade of D, highlighting the relative undervaluation of ALGN [6].

Core Insights - Align Technology's (ALGN) efforts to expand the Invisalign business are expected to drive significant growth in the coming quarters, alongside advancements in iTero intraoral scanning technology [1][9] - The company has a strong financial position with zero debt and substantial cash flow, although foreign exchange challenges pose risks to its operations [9][10] Financial Performance - Over the past year, ALGN shares have decreased by 22.2%, while the industry saw a decline of 1.6%, and the S&P 500 composite increased by 11.3% [2] - The company's market capitalization stands at $11.66 billion, with a long-term estimated earnings growth rate of 11.2%, surpassing the industry's 9.9% [2] - ALGN has consistently exceeded earnings estimates in the last four quarters, with an average surprise of 3.4% [2] Business Developments - The Invisalign portfolio is expanding, with recent approvals for the Invisalign Palatal Expander in Turkey and the introduction of the Mandibular Advancement system in multiple countries [4][5] - ALGN has strengthened partnerships with global dental service organizations to enhance digital adoption in dentistry [6] - The iTero intraoral scanners are gaining traction globally, with new restorative capabilities and software upgrades announced in the first quarter [7][9] Solvency and Cash Flow - Align Technology maintains a strong liquidity position with no debt, reporting cash and cash equivalents of $873 million in the first quarter [10] - The cumulative net cash from operating activities increased to $52.2 million compared to $28 million in the previous year [10] Market Challenges - Foreign exchange fluctuations are a significant concern, impacting revenues as a large portion is generated outside the U.S. [11] - Both business segments experienced adverse effects from unfavorable foreign exchange rates in the first quarter [11] Earnings Estimates - The Zacks Consensus Estimate for 2025 earnings per share (EPS) remains at $10.33, with revenues projected at $4.15 billion, indicating a 3.9% increase from the previous year [12]

Company Overview - Align Technology (NASDAQ: ALGN) is recognized as a market leader in the digital dentistry platform sector, yet it is still valued by the market similarly to traditional orthodontic device companies [1] Market Opportunity - There exists a significant opportunity for Align Technology in underpenetrated scanner bases and the development of emerging recurring revenue streams [1] Market Sentiment - The current market sentiment remains pessimistic regarding Align Technology, despite the potential for growth and innovation within the company [1]

Align Technology (ALGN) 2025 Conference Summary Company Overview - **Company**: Align Technology (ALGN) - **Event**: Jefferies 2025 New York Healthcare Conference - **Date**: June 04, 2025 - **Speakers**: Simon Beard (EVP, EMEA), Shirley Stacy (VP Finance), Evelyn Valenti Key Industry Insights Innovation and Technology - Align Technology is entering a phase of significant innovation, focusing on game-changing technologies such as: - **ClinCheck Software**: Transitioning from a manual process to a touchless phase using algorithms and AI, leading to productivity gains for clinicians and the company [3][4] - **Direct Printing**: Eliminating the vacuum forming process in manufacturing Invisalign products, enhancing efficiency [4] - **New Scanning Technology**: Introduction of multidirectional capture technology, opening new development avenues [5] Market Dynamics - The company has seen strong growth in the Asia Pacific and EMEA regions, indicating a balanced global business model [6] - EMEA presents a significant opportunity for expansion, with many markets still underpenetrated despite long-term presence [11][12] Regional Differences - The EMEA market has similarities to North America in terms of digitizing doctor practices, but also faces unique challenges: - Different regulatory environments and advertising laws across European countries [15][16] - Structural differences in how orthodontists and general dentists operate in various markets [17] Growth Projections - Align Technology anticipates a volume growth of 5% to 15% during the ORP period, with acceleration beyond 15% thereafter [26] Strategic Initiatives Peer-to-Peer Program - The company has implemented a peer-to-peer mentorship program to support inexperienced orthodontists, resulting in significant growth in their practices: - Mentees can experience a 5-6x increase in growth, with even higher rates in the kids and teen segment [36] Product Launches - Recent product launches include: - **Palatal Expander**: First new device in over 50 years, showing promising adoption and positive feedback from doctors [41][44] - **Mandibular Advancement Device**: Early feedback indicates effective results, though longer-term outcomes are still being assessed [45] - **Lumina Restorative**: Positive market response noted for its efficiency and photorealism [47] Addressing General Practitioner (GP) Opportunities - The company is focusing on training general dentists with iTero scanners to optimize workflows and improve patient consultations [63][65] - A strategy is in place to support existing general dentists who perform few cases, enhancing their confidence and efficiency through treatment planning services [69] Conclusion - Align Technology is positioned for growth through innovation, strategic regional expansion, and targeted support for practitioners. The company is committed to leveraging its technological advancements to enhance productivity and market penetration in the EMEA region and beyond.

Company Overview - Align Technology (ALGN) shares have increased by approximately 3.6% over the past month, underperforming the S&P 500 index [1] - The most recent earnings report is crucial for understanding the key drivers affecting the stock [1] Earnings Estimates - Estimates for Align Technology have trended downward in the past month, indicating a potential concern for future performance [2][4] - The stock currently holds a Zacks Rank of 3 (Hold), suggesting an expectation of in-line returns in the upcoming months [4] VGM Scores - Align Technology has an average Growth Score of C, a Momentum Score of D, and a Value Score of C, placing it in the middle 20% for the value investment strategy [3] - The aggregate VGM Score for Align Technology is C, which is relevant for investors not focused on a single strategy [3] Industry Performance - Align Technology is part of the Zacks Medical - Dental Supplies industry, which includes Labcorp (LH) [5] - Labcorp has experienced a 2.3% increase in shares over the past month, with reported revenues of $3.35 billion for the last quarter, reflecting a year-over-year growth of 5.3% [5] - Labcorp's earnings per share (EPS) for the last quarter was $3.84, compared to $3.68 a year ago, and it is expected to post earnings of $4.12 per share for the current quarter, indicating a 4.6% increase from the previous year [6]

Align Technology (ALGN) 2025 Conference Summary Company Overview - **Company**: Align Technology (ALGN) - **Event**: 2025 Stifel Jaws and Paws Conference - **Date**: May 28, 2025 Key Points Industry and Market Dynamics - **Overall Market Growth**: Align Technology reported double-digit growth in Asia and Europe, while North America remained relatively flat [4][20] - **Consumer Confidence**: The company noted a divergence between Google Trends and consumer confidence indices, suggesting that both metrics should be considered together for a comprehensive view of market interest [8][11] - **Geographic Performance**: - **APAC**: Strong growth due to stable economies post-COVID, with Japan and China performing well [21][22] - **EMEA**: Mixed results with strong performance in Spain, Italy, and the UAE, while Germany faced challenges [24] Financial Performance and Guidance - **Revenue Guidance**: The company raised its revenue guidance for 2025, attributing this to favorable foreign exchange rates and consistent volume growth [15][17] - **Gross Margin**: The gross margin was reported at 22.5%, with efforts to offset tariff impacts and improve productivity [17][18] - **Long-Range Plan (LRP)**: The company expressed confidence in achieving double-digit growth in APAC and EMEA, with modest growth expected in North America [42][43] Product and Innovation - **New Products**: Introduction of new products like IPE and MAOB aimed at expanding market reach, particularly in the teen segment [25][29] - **Conversion Tools**: Enhanced conversion rates through new tools that allow immediate treatment simulations during patient consultations [12][13] - **Direct Fabrication**: The company is transitioning to direct fabrication, which is expected to be dilutive in 2025 and 2026 but accretive by 2027 due to material cost savings [61][63] Competitive Landscape - **Market Competition**: Align Technology acknowledged increased competition but noted a more respectful pricing strategy among competitors as the market growth slows [75][78] - **Pricing Strategy**: The company is focused on maintaining pricing integrity while navigating the competitive landscape, particularly against lab-based players [76][79] Strategic Initiatives - **Advertising Strategy**: The company plans to increase direct-to-consumer advertising for new products once they gain traction in the market [30][31] - **Sales Force Engagement**: Strengthening relationships with partners like Heartland to drive consumer demand and leverage distribution channels [27][28] Miscellaneous Insights - **Tariff Impact**: The company is managing a monthly tariff impact of approximately $1 million, primarily affecting scanner flows from Israel to the U.S. [17] - **Technological Advancements**: The introduction of the Lumina platform is expected to set a new standard in intraoral scanning technology, enhancing operational efficiency [50][52] This summary encapsulates the key insights and strategic directions discussed during the Align Technology conference, highlighting the company's performance, market dynamics, and future growth prospects.

Core Viewpoint - The analysis compares Align Technology (ALGN) and Merit Medical (MMSI) to determine which stock is more attractive to value investors, highlighting ALGN's stronger earnings outlook and better valuation metrics [1][3]. Valuation Metrics - ALGN has a forward P/E ratio of 16.57, while MMSI has a forward P/E of 28.45, indicating that ALGN is potentially undervalued compared to MMSI [5]. - The PEG ratio for ALGN is 1.48, suggesting a favorable earnings growth outlook, whereas MMSI's PEG ratio is 2.77, indicating a less attractive growth relative to its price [5]. - ALGN's P/B ratio stands at 3.30, compared to MMSI's P/B of 3.95, further supporting ALGN's valuation advantage [6]. Earnings Outlook - ALGN is noted for its improving earnings outlook, which enhances its attractiveness in the Zacks Rank model, suggesting it is a superior value option compared to MMSI [7].

Core Viewpoint - Align Technology, Inc.'s Invisalign Palatal Expander System has received approval from the National Medical Products Administration in China, allowing for broad patient applicability and expected commercial availability in the second half of 2025 [1][3]. Company Developments - The approval of the Invisalign Palatal Expander System marks a significant milestone in the company's efforts to improve clinical outcomes and efficiency in orthodontics [2]. - The Invisalign Palatal Expander System is a modern, innovative direct 3D-printed device designed for rapid expansion of the upper jaw during patient treatment [5]. - The system consists of a series of removable devices that are customized to the patient's unique anatomy using the company's iTero intraoral digital scan [6]. - Align Technology has also made its Invisalign System with mandibular advancement commercially available, which is designed for Class II skeletal and dental correction [11]. Market Performance - Following the announcement of the approval, ALGN's shares decreased by 0.5% to $183.4 in after-market trading [3]. - Currently, Align Technology has a market capitalization of $13.53 billion and an estimated long-term earnings growth rate of 11.2%, compared to the industry's 9.8% [4]. - In the past month, ALGN's shares have declined by 31.7%, while the industry experienced a 5% decline [12]. Industry Prospects - The global 3D printing market is projected to grow from $17.5 billion in 2024 at a compound annual growth rate of 16.4% through 2029, indicating a favorable environment for companies like Align Technology [8].

Summary of Align Technology Conference Call Company Overview - **Company**: Align Technology - **Industry**: Dental and Orthodontic Technology Key Points and Arguments 1. Q1 Results and Growth - Align Technology reported better-than-expected Q1 results, with growth across both orthodontic (ortho) and general practice (GP) segments, including both teen and adult markets [4][5][6] 2. Analyst Day Insights - The recent Analyst Day provided updates on innovations in digital scanning, software, and 3D printing, emphasizing the importance of technology in digitizing orthodontic practices [8][9][10] 3. Long-Range Plan (LRP) Updates - The new LRP indicates growth expectations of 5-15% from 2026 to 2028, with over 15% growth anticipated in 2029 and beyond, driven by innovations and market expansion [11][12][18] 4. Innovations Driving Growth - Key innovations include the Invisalign Palatal Expander for younger patients and the occlusal block for teenagers, addressing significant market needs [13][14][15] - The company is focusing on expanding its product portfolio to cater to various demographics and price points [17][18] 5. Market Resilience - Align Technology is confident in its ability to drive adoption and utilization globally, independent of macroeconomic conditions, particularly in the near term [19][20] 6. Direct Fabrication (DirectFab) - DirectFab is in early stages but is expected to enhance manufacturing capabilities and product offerings, with a focus on customization and efficiency [30][33][34] 7. Regional Market Insights - The U.S. market has shown stability, with a mix of GP and ortho channels, while Canada has a GP-driven model. Latin America presents unique opportunities, particularly in Brazil and Mexico, where affordability and multidisciplinary practices are key [38][48][52][56] 8. Competitive Landscape - The exit of some direct-to-consumer (DTC) competitors presents opportunities for Align to capture market share, leveraging its comprehensive product portfolio [45][46] 9. Education and Customer Engagement - Align Technology emphasizes the importance of education and peer-to-peer community building among doctors, with over 500 live education events planned in the U.S. [41][42][50] 10. Tariff Concerns - Current tariff impacts are manageable, primarily affecting iTero products from Israel, with no significant changes anticipated in the near future [59][60] 11. Doctor-Centric Approach - Align Technology focuses on building trust with doctors, emphasizing that successful outcomes depend on the confidence doctors have in Align's products and workflows [64][65] Additional Important Content - The company is leveraging technology to enhance patient awareness and treatment options, aiming for a seamless integration of orthodontic and restorative workflows [26][27][29] - Align Technology is committed to addressing market needs through continuous innovation and customer feedback, ensuring that its offerings remain relevant and effective [21][22][23]